Bottom line
PRHSX vs SHSSX: the short answer
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) share a meaningful slice of their top holdings — about 72% by weight.
PRHSX is cheaper at 0.83% vs 0.86% — a difference of $3.00 a year per $10,000 invested.
Over five years, SHSSX returned +5.9% a year vs +4.2% for PRHSX.
Updated Nov 19, 2026
PRHSX vs SHSSX side by side
| PRHSX | SHSSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | T. Rowe Price | BlackRock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.83% | 0.86% |
| Annual cost per $10k | $83 | $86 |
| 10-yr cost on $10k (prospectus) | $1,025 | $1,061 |
| Max front load | — | 0% |
| 12b-1 fee | — | 0% |
| 1-yr return | +17.7% | +16.3% |
| 5-yr return (annualized) | +4.2% | +5.9% |
| 10-yr return (annualized) | +9.1% | +9.8% |
| Best quarter | +23.5% | — |
| Worst quarter | −15.8% | — |
| Net assets (fund) | $11.9B | $5.9B |
| Number of holdings | 279 | 155 |
| Portfolio turnover | 62% | 49% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
14 of PRHSX's top 25 holdings also appear in SHSSX's top 25.
| Holding | PRHSX | SHSSX |
|---|---|---|
| Eli Lilly & Co | 14.28% | 12.29% |
| Johnson & Johnson | 6.63% | 8.77% |
| Unitedhealth Group Inc | 5.99% | 6.10% |
| Abbvie Inc | 5.10% | 3.94% |
| Merck & Co. Inc. | 4.01% | 4.94% |
| Gilead Sciences Inc | 2.82% | 4.19% |
| Thermo Fisher Scientific Inc | 2.52% | 3.02% |
| Vertex Pharmaceuticals Inc | 2.28% | 2.74% |
| Abbott Laboratories | 1.89% | 1.97% |
| Intuitive Surgical Inc | 1.87% | 1.95% |
| Amgen Inc | 1.82% | 3.37% |
| Stryker Corp | 1.78% | 1.15% |
| Elevance Health Inc | 1.53% | 1.56% |
| Danaher Corp | 1.43% | 2.00% |
Source: SEC Form N-PORT
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
FAQ
What is the difference between PRHSX and SHSSX?
Which is cheaper, PRHSX or SHSSX?
Should I own both PRHSX and SHSSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.